ask our doctors

Cirrhosis

Get the facts on Cirrhosis treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Cirrhosis prevention, screening, research, statistics and other Cirrhosis related topics. We answer all your qestions about Cirrhosis.

Question: How bad is level 4 cirrhosis and what is the life expectancy? If a smoker with diabetes has level 4 cirrhosis of the liver due to alcohol abuse and Hepatitis B, what is the likelyhood of liver failure? About how many years could they live this way? How long could they life this way if they stop drinking?

Answer: I'm not sure what classification you are using for your "level 4 cirrhosis". Mostly the Child-Pugh classification is used.


Cirrhosis News

Cirrhosis patients losing muscle mass have a higher death rate

EurekAlert (press release)
These cirrhosis patients were placed at a lower spot on the transplant list because they had a higher functioning liver and were seemingly less sick than others with the same condition, based on scoring systems physicians commonly use today.
 

Hepatocellular carcinoma

OnMedica
Cirrhosis is known to be the greatest risk factor for the development of HCC. Significant geographical differences are apparent in relation to this risk factor. HCC rates of 30% are reported in South Africa but lower rates of 20% in Great Britain and ...
 

The Voice of Russia

Liver cirrhosis curable
The Voice of Russia
 

Sarcopenia Predictive of Mortality in Cirrhosis

Doctors Lounge
In patients with cirrhosis being evaluated for liver transplantation, sarcopenia is associated with increased mortality and significantly lower median survival time, according to research published in the February issue of Clinical Gastroenterology and ...
 

News Tribe

DUHS inaugurates Bleeding Care Unit at NILGID
News Tribe
 

Rituximab possible treatment option for patients with primary biliary cirrhosis

Medical Xpress
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, also known as Ursodiol.
 

ABC News (blog)

Tragedy, and Luck, Leads to Miracle Organ Transplant for Coach
ABC News (blog)
 

Coffee Lowers Liver Fibrosis Risk in Certain Patients

Medscape
Dr. Klatsky was not involved in the present study, but he was the lead author of the first paper linking coffee intake to cirrhosis, published in 1992. The new finding comes from a validated caffeine questionnaire administered to 4 patient groups at ...
 

Rituximab shows promise against primary biliary cirrhosis

News-Medical.net
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, also known as Ursodiol.
 

Cirrhosis Patients Have High Disability, Caregiving Needs

Medscape
January 12, 2012 ? Older adults with cirrhosis carry a heavy burden of physical handicaps compared with those without the disease, including worse health status, more comorbidities, greater functional disability, and a need for substantially more ...